Table 1.
Genotype | p53 loss/restoration | Tumors | Effects on tumor growth | Cellular response | Reference |
---|---|---|---|---|---|
p53LSL/LSL;Cre-ERT2 | Germline | Lymphomas | Regression | Apoptosis | Ventura et al. (2007) |
Sarcomas | Regression; stasis | Cell cycle arrest; senescence | |||
p53Neo/−;CAG-CreER | Germline | Lymphomas | Regression | Apoptosis | Wang et al. (2011) |
Angiosarcomas | Regression | Senescence | |||
p53Neo/R172H;CAG-CreER | Germline | Lymphomas | Stasis | Apoptosis; senescence | Wang et al. (2011) |
Angiosarcomas | Stasis | Senescence; decreased cell proliferation | |||
p53Neo/R172H;Cre-ERT2 | Germline | Lymphomas | Mixed | Apoptosis | Larsson et al. (2018) |
HaRasV12;p53 shRNA | Carcinoma only | Hepatocellular carcinomas | Regression | Senescence; immune response | Xue et al. (2007) |
Eμ-myc;p53ERTAM/+ | B-cells | B-cell lymphomas | Delay | Apoptosis | Martins et al. (2006) |
Mdm2Tg;p53Neo/Neo;CAG-CreER | Germline | Angiosarcomas | Stasis | Decreased proliferation; senescence | Li et al. (2014) |